Monitoring Therapy with Gene Expression Profiling Reveals Physiological Differences in Drug Action

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|10|16|1959-1968

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.10, Iss.16, 2004-06, pp. : 1959-1968

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multiple Sclerosis Therapy Monitoring Based on Gene Expression

By  

Current Pharmaceutical Design, Vol. 12, Iss. 29, 2006-10 ,pp. : 3761-3779

Bentham Science Publishers

Access to resources Recommend Favorite

HIF-1 Inhibitors for Cancer Therapy: From Gene Expression to Drug Discovery

By  

Current Pharmaceutical Design, Vol. 15, Iss. 33, 2009-11 ,pp. : 3839-3843

Bentham Science Publishers

Access to resources Recommend Favorite

DNA Microarray-Based Gene Expression Profiling in Cancer: Aiding Cancer Diagnosis, Assessing Prognosis and Predicting Response to Therapy

By  

Current Pharmacogenomics, Vol. 3, Iss. 4, 2005-12 ,pp. : 289-304

Bentham Science Publishers

Access to resources Recommend Favorite

Microarray Expression Profiling Reveals Candidate Genes for Human Uterine Receptivity

By Linda C. Giudice  

American Journal of PharmacoGenomics, Vol. 4, Iss. 5, 2004-01 ,pp. : 299-312

Adis International

Access to resources Recommend Favorite

Pharmacogenetic differences and drug–drug interactions in immunosuppressive therapy

By Warrington Jill S   Shaw Leslie M  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 1, Iss. 3, 2005-10 ,pp. : 487-503

Informa Healthcare

Access to resources Recommend Favorite